Enhanced Antiviral Activity Against Foot-and-mouth Disease Virus by a Combination of Type I and Ii Porcine Interferons.
From: Plum Island Animal Disease Center, USDA, ARS, NAA, P.O. Box 848, Greenport, NY 11944, USA.
Journal of virology
- Publish Date: Jul 2007
- ISSN: 0022-538X
- Volume: 81
- Issue: 13
- Pages: 7124-35
- Medium: Print
- Language: English
- Citation (JAMA): Moraes Mauro Pires, de Los Santos Teresa, Koster Marla, et al. Enhanced Antiviral Activity Against Foot-and-mouth Disease Virus by a Combination of Type I and Ii Porcine Interferons.. J. Virol. Jul 2007;81:7124-35
Abstract
Previously, we showed that type I interferon (alpha/beta interferon [IFN-alpha/beta]) can inhibit foot-and-mouth disease virus (FMDV) replication in cell culture, and swine inoculated with 10(9) PFU of human adenovirus type 5 expressing porcine IFN-alpha (Ad5-pIFN-alpha) were protected when challenged 1 day later. In this study, we found that type II pIFN (pIFN-gamma) also has antiviral activity against FMDV in cell culture and that, in combination with pIFN-alpha, it has a synergistic antiviral effect. We also observed that while each IFN alone induced a number of IFN-stimulated genes (ISGs), the combination resulted in a synergistic induction of some ISGs. To extend these studies to susceptible animals, we inoculated groups of swine with a control Ad5, 10(8) PFU of Ad5-pIFN-alpha, low- or high-dose Ad5-pIFN-gamma, or a combination of Ad5-pIFN-alpha and low- or high-dose Ad5-pIFN-gamma and challenged all groups with FMDV 1 day later. The control group and the groups inoculated with either Ad5-pIFN-alpha or a low dose of Ad5-pIFN-gamma developed clinical disease and viremia. However, the group that received the combination of both Ad5-IFNs with the low dose of Ad5-pIFN-gamma was completely protected from challenge and had no viremia. Similarly the groups inoculated with the combination of Ad5s with the higher dose of Ad5-pIFN-gamma or with only high-dose Ad5-pIFN-gamma were protected. The protected animals did not develop antibodies against viral nonstructural (NS) proteins, while all infected animals were NS protein seropositive. No antiviral activity or significant levels of IFNs were detected in the protected groups, but there was an induction of some ISGs. The results indicate that the combination of type I and II IFNs act synergistically to inhibit FMDV replication in vitro and in vivo.
Mesh Headings (Keywords): Adenoviridae, Animals, Antibodies, Viral, Antiviral Agents, Cell Line, Cricetinae, Foot-and-Mouth Disease, Foot-and-Mouth Disease Virus, Gene Expression Regulation, Gene Therapy, Humans, Interferon Type II, Interferon-alpha, Sheep, Swine, Viral Nonstructural Proteins, Virus Replication
Check for Full Text / PubMed Unique Identifier (PMID): 17459931
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.